{"id":"https://openalex.org/W3153679908","doi":"https://doi.org/10.55320/mjz.48.1.59","title":"A Case Report of Tenofovir Alafenamide Induced Alopecia in a Zambian Teenager: A call for Pharmacovigilance","display_name":"A Case Report of Tenofovir Alafenamide Induced Alopecia in a Zambian Teenager: A call for Pharmacovigilance","publication_year":2021,"publication_date":"2021-04-07","ids":{"openalex":"https://openalex.org/W3153679908","doi":"https://doi.org/10.55320/mjz.48.1.59","mag":"3153679908"},"language":"en","primary_location":{"id":"doi:10.55320/mjz.48.1.59","doi":"https://doi.org/10.55320/mjz.48.1.59","is_oa":true,"landing_page_url":"http://dx.doi.org/10.55320/mjz.48.1.59","pdf_url":null,"source":{"id":"https://openalex.org/S2764364198","display_name":"Medical Journal of Zambia","issn_l":"0047-651X","issn":["0047-651X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310321518","host_organization_name":"African Journals OnLine","host_organization_lineage":["https://openalex.org/P4310321518"],"host_organization_lineage_names":["African Journals OnLine"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Journal of Zambia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://dx.doi.org/10.55320/mjz.48.1.59","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047979318","display_name":"Benedict Moonga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benedict Moonga","raw_affiliation_strings":["Department of Paediatrics and Child Health, Livingstone Central Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Paediatrics and Child Health, Livingstone Central Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037392785","display_name":"Jean M Mukumbuta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802600546","display_name":"Livingstone Hospital","ror":"https://ror.org/00f0wme23","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I2802600546"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"M Jean Mukumbuta","raw_affiliation_strings":["Department of Pharmacy, Pharmacovigilance Focal Point Person, Livingstone Central Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Pharmacovigilance Focal Point Person, Livingstone Central Hospital","institution_ids":["https://openalex.org/I2802600546"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069233246","display_name":"Malan Malumani","orcid":"https://orcid.org/0000-0002-9149-002X","observed_orcids":["https://orcid.org/0000-0002-9149-002X"]},"institutions":[{"id":"https://openalex.org/I2802600546","display_name":"Livingstone Hospital","ror":"https://ror.org/00f0wme23","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I2802600546"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Malan Malumani","raw_affiliation_strings":["Dermatology and Venereology Unit, Department of Internal Medicine, Livingstone Central Hospita"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology and Venereology Unit, Department of Internal Medicine, Livingstone Central Hospita","institution_ids":["https://openalex.org/I2802600546"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":"1","first_page":"63","last_page":"66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.6685000061988831,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.6685000061988831,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.23800000548362732,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":0.03819999843835831,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tenofovir-alafenamide","display_name":"tenofovir alafenamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/alopecia","display_name":"hair loss","score":0.9139999747276306},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.843999981880188},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.9190000295639038},{"id":"https://openalex.org/keywords/hiv-treatment","display_name":"HIV treatment","score":0.7549999952316284},{"id":"https://openalex.org/keywords/antiretroviral-drugs","display_name":"antiretroviral drugs","score":0.8420000076293945},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5809999704360962},{"id":"https://openalex.org/keywords/adverse-drug-reaction-reporting","display_name":"adverse drug reaction reporting","score":0.6349999904632568},{"id":"https://openalex.org/keywords/adolescent-patient","display_name":"adolescent patient","score":0.3199999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9331661462783813},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.8850672245025635},{"id":"https://openalex.org/C2911190787","wikidata":"https://www.wikidata.org/wiki/Q22075912","display_name":"Tenofovir alafenamide","level":5,"score":0.8336755037307739},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5937514305114746},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5102229118347168},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.46164315938949585},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4458867311477661},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.4430348575115204},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3739546537399292},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37286126613616943},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3424338698387146},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.23175817728042603},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1844893991947174},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.1121821403503418},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08752825856208801},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.07202190160751343},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.55320/mjz.48.1.59","doi":"https://doi.org/10.55320/mjz.48.1.59","is_oa":true,"landing_page_url":"http://dx.doi.org/10.55320/mjz.48.1.59","pdf_url":null,"source":{"id":"https://openalex.org/S2764364198","display_name":"Medical Journal of Zambia","issn_l":"0047-651X","issn":["0047-651X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310321518","host_organization_name":"African Journals OnLine","host_organization_lineage":["https://openalex.org/P4310321518"],"host_organization_lineage_names":["African Journals OnLine"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Journal of Zambia","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.55320/mjz.48.1.59","doi":"https://doi.org/10.55320/mjz.48.1.59","is_oa":true,"landing_page_url":"http://dx.doi.org/10.55320/mjz.48.1.59","pdf_url":null,"source":{"id":"https://openalex.org/S2764364198","display_name":"Medical Journal of Zambia","issn_l":"0047-651X","issn":["0047-651X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310321518","host_organization_name":"African Journals OnLine","host_organization_lineage":["https://openalex.org/P4310321518"],"host_organization_lineage_names":["African Journals OnLine"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Journal of Zambia","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1522740795","https://openalex.org/W1987991358","https://openalex.org/W2062796821","https://openalex.org/W2121120728","https://openalex.org/W2162718944","https://openalex.org/W2269807470","https://openalex.org/W2592828491","https://openalex.org/W2758631227","https://openalex.org/W2911475549","https://openalex.org/W2963543151","https://openalex.org/W4327847694"],"related_works":["https://openalex.org/W4313045252","https://openalex.org/W4321748986","https://openalex.org/W2757630530","https://openalex.org/W7164005142","https://openalex.org/W3183412474","https://openalex.org/W7071831622","https://openalex.org/W4379400217","https://openalex.org/W2896227896","https://openalex.org/W3194363948","https://openalex.org/W2185687677"],"abstract_inverted_index":{"Adverse":[0,43],"drug":[1],"reactions":[2],"continue":[3],"to":[4,17,76,95,100,110],"pose":[5],"a":[6,55,65,74,92],"global":[7],"risk":[8],"in":[9,68],"the":[10,19,69,107],"fight":[11],"against":[12],"HIV.":[13],"In":[14],"an":[15],"attempt":[16],"attain":[18],"end":[20],"AIDS":[21],"pandemic":[22],"by":[23],"2030,":[24],"newer":[25],"drugs":[26,40],"are":[27],"being":[28],"formulated":[29],"with":[30],"better":[31],"efficacy":[32],"and":[33,51,102,105],"fewer":[34],"side":[35],"effects.":[36],"However,":[37],"these":[38],"new":[39],"still":[41],"have":[42,84],"Drug":[44],"Reactions":[45],"(ADRs),":[46],"which":[47,79],"may":[48,80,82],"affect":[49,111],"adherence":[50],"compliance.":[52],"We":[53],"present":[54],"rare":[56],"case":[57],"of":[58,64,71],"Tenofovir":[59],"Alafenamide":[60],"(TAF)":[61],"induced":[62],"alopecia":[63],"Zambian":[66],"teenager":[67],"context":[70],"pharmacovigilance":[72],"as":[73],"tool":[75],"identify":[77,101],"ADRs,":[78],"or":[81],"not":[83],"been":[85],"identified":[86],"during":[87],"clinical":[88],"trials.":[89],"This":[90],"is":[91],"wake-up":[93],"call":[94],"all":[96],"health":[97],"care":[98],"workers":[99],"report":[103],"ADRs":[104],"use":[106],"established":[108],"channels":[109],"policy":[112],"change.":[113]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2021-04-26T00:00:00"}